These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 17335665)

  • 1. Pharmacokinetics of metadoxine for injection after repeated doses in healthy volunteers.
    Lü Y; Kang ZS; Liu Y; Li TY; Xiao YH
    Chin Med J (Engl); 2007 Jan; 120(2):166-8. PubMed ID: 17335665
    [No Abstract]   [Full Text] [Related]  

  • 2. Negligible effect of oral garlic oil on the oral absorption of pyridoxine in metadoxine in rats.
    Lee DY; Kang HE; Kim SG; Lee MG
    Arch Pharm Res; 2010 Jul; 33(7):1005-8. PubMed ID: 20661709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic use of metadoxine in alcohol-related mental and behavioral disorders].
    Carboni MA; Corsa R
    Clin Ter; 1987 Dec; 123(6):469-73. PubMed ID: 2972505
    [No Abstract]   [Full Text] [Related]  

  • 4. Metadoxine in the treatment of acute and chronic alcoholism: a review.
    Addolorato G; Ancona C; Capristo E; Gasbarrini G
    Int J Immunopathol Pharmacol; 2003; 16(3):207-14. PubMed ID: 14611722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of metadoxyl in the treatment of the hepatotoxic effects of cytostatics].
    Safonova SA; Gershanovich ML
    Vopr Onkol; 2005; 51(5):599-600. PubMed ID: 16756021
    [No Abstract]   [Full Text] [Related]  

  • 6. [Metadoxine in the treatment of vomiting in uremic patients under dialysis treatment].
    Di Paolo N; De Mia M; Gaggiotti E
    Clin Ter; 1984 Aug; 110(3):221-9. PubMed ID: 6237861
    [No Abstract]   [Full Text] [Related]  

  • 7. [Metadoxine in alcohol-related pathology].
    Santoni S; Corradini P; Zocchi M; Camarri F
    Clin Ter; 1989 Jul; 130(2):115-22. PubMed ID: 2529084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined metadoxine and garlic oil treatment efficaciously abrogates alcoholic steatosis and CYP2E1 induction in rat liver with restoration of AMPK activity.
    Ki SH; Choi JH; Kim CW; Kim SG
    Chem Biol Interact; 2007 Aug; 169(2):80-90. PubMed ID: 17606256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of alcoholic hepatic steatosis with metadoxine. Preliminary results on the evaluation of the effects of the drug by an ultrasonographic study].
    Sergiacomo L; Ciancaglini R; Orlando D; Delle Monache G; Pesa O
    Clin Ter; 1986 Oct; 119(2):133-41. PubMed ID: 3539468
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute alcohol intoxication.
    Vonghia L; Leggio L; Ferrulli A; Bertini M; Gasbarrini G; Addolorato G;
    Eur J Intern Med; 2008 Dec; 19(8):561-7. PubMed ID: 19046719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyridoxol L,2-pyrrolidon-5 carboxylate prevents active fibroplasia in CCl4-treated rats.
    Annoni G; Contu L; Tronci MA; Caputo A; Arosio B
    Pharmacol Res; 1992 Jan; 25(1):87-93. PubMed ID: 1310810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metadoxine, an ion-pair of pyridoxine and L-2-pyrrolidone-5-carboxylate, blocks adipocyte differentiation in association with inhibition of the PKA-CREB pathway.
    Yang YM; Kim HE; Ki SH; Kim SG
    Arch Biochem Biophys; 2009 Aug; 488(2):91-9. PubMed ID: 19607801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Metadoxyl in combined treatment of alcohol damage to the liver].
    Vedrova NN; Gnezdilova NIu
    Klin Med (Mosk); 2001; 79(4):56-8. PubMed ID: 11496744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of pyridoxine-pyrrolidon-carboxylate on hepatic and cerebral ATP levels in ethanol treated rats.
    Felicioli R; Saracchi I; Flagiello AM; Bartoli C
    Int J Clin Pharmacol Ther Toxicol; 1980 Jun; 18(6):277-80. PubMed ID: 7192694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of alcoholic fatty liver: is the metabolic effect of metadoxine the only reason for improved liver function?
    Stefanini GF; Addolorato G; Caputo F; Bernardi M; Gasbarrini G
    J Hepatol; 1999 Apr; 30(4):739-40. PubMed ID: 10207820
    [No Abstract]   [Full Text] [Related]  

  • 16. [The use of hepatic protectors in clinical practice].
    Minushkin ON; Maslovskiĭ LV; Bukshuk AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(10 Pt 2):67-72. PubMed ID: 23250615
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of acute alcohol intoxication: The role of metadoxine.
    Mirijello A; Addolorato G
    Eur J Intern Med; 2023 Apr; 110():128. PubMed ID: 36797119
    [No Abstract]   [Full Text] [Related]  

  • 18. A follow up study on the efficacy of metadoxine in the treatment of alcohol dependence.
    Guerrini I; Gentili C; Nelli G; Guazzelli M
    Subst Abuse Treat Prev Policy; 2006 Dec; 1():35. PubMed ID: 17176456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology, Systematic Review and Recent Clinical Trials of Metadoxine.
    Di Miceli M; Gronier B
    Rev Recent Clin Trials; 2018; 13(2):114-125. PubMed ID: 29485008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacokinetics of nalmefene after a single or multiple intravenous doses in Chinese healthy volunteers].
    Liao RF; Zeng ZP; Wen YG
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Oct; 28(10):1816-9. PubMed ID: 18971181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.